Ads
related to: dedifferentiated endometrial carcinoma treatment guidelines- EC Treatment Options
Learn About An Endometrial Cancer
Treatment Option For Your Patients.
- EC Treatment Information
Read About A Type Of EC Treatment
And View Treatment Information.
- Review A Safety Profile
See The Adverse Reactions Of A
Pivotal Clinical Trial.
- Access & Support Options
Explore The Options Together
In One Easy-To-Access Location.
- Discover A Trial
To Understand The Efficacy
Of An Endometrial Cancer Treatment.
- See The Lab Abnormalities
And Safety Info Of A Clinical Trial
Learn More About An EC Treatment.
- EC Treatment Options
Search results
Results From The WOW.Com Content Network
High-grade serous carcinoma (HGSC) is a type of tumour that arises from the serous epithelial layer in the abdominopelvic cavity and is mainly found in the ovary.HGSCs make up the majority of ovarian cancer cases [1] and have the lowest survival rates. [2]
The leading treatment option for endometrial cancer is abdominal hysterectomy (the total removal by surgery of the uterus), together with removal of the Fallopian tubes and ovaries on both sides, called a bilateral salpingo-oophorectomy. [4] In more advanced cases, radiation therapy, chemotherapy or hormone therapy may also be recommended. [4]
Treatment of uterine cancer may differ depending on the type of cancer and staging of the tumor. [15] In early stages, minimal invasive surgery is preferred. [16] For endometrial cancer, five main types of treatments are used, including surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy
Uterine clear-cell carcinoma (CC) is a rare form of endometrial cancer with distinct morphological features on pathology; it is aggressive and has high recurrence rate. Like uterine papillary serous carcinoma CC does not develop from endometrial hyperplasia and is not hormone sensitive, rather it arises from an atrophic endometrium.
Merck (MRK) receives accelerated approval for label expansion of Keytruda in combination with Lenvima for treating certain types of endometrial carcinoma. Its Ebola vaccine BLA gets priority review.
There is an association with endometriosis and concurrent primary endometrial carcinoma (endometrial cancer). On gross pathological examination, the tumor is cystic and may be solid and some arise in cystic endometriosis. In 40% of cases, endometrioid tumors are found bilaterally. [3]
Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy , prompted by post-menopausal bleeding .
Carcinosarcoma of the uterus. In gross appearance, MMMTs are fleshier than adenocarcinomas, may be bulky and polypoid, and sometimes protrude through the cervical os.On histology, the tumors consist of adenocarcinoma (endometrioid, serous or clear cell) mixed with the malignant mesenchymal elements; alternatively, the tumor may contain two distinct and separate epithelial and mesenchymal ...
Ad
related to: dedifferentiated endometrial carcinoma treatment guidelines